SC
CME icon

Scholtz & Company’s CME Group CME Stock Holding History

Scholtz & Company’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-9,230
Closed -$1.57M – 47
2018
Q3 		$1.57M Sell
9,230
-5,015
-35% -$844K 0.99% 32
2018
Q2 		$2.33M Buy
14,245
+25
+0.2% +$4.08K 1.63% 26
2018
Q1 		$2.3M Buy
+14,220
New +$2.26M 1.7% 27

Other funds holding CME

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Scholtz & Company's CME Position: Q4 2018 in Review

Scholtz & Company sold out of CME Group (CME) in Q4 2018, closing a stake of 9,230 shares — an estimated $1.57M sold.

Scholtz & Company first reported a position in CME in Q1 2018 and held it in 3 quarters. The position peaked at $2.33M in Q2 2018. 1,014 funds tracked by Wall St. Rank hold CME as of Q4 2018.

  • Scholtz & Company reported no remaining CME Group position as of Q4 2018 after selling out during the quarter.
  • Scholtz & Company sold 9,230 CME Group shares in Q4 2018, an estimated $1.57M.
  • Scholtz & Company first reported a position in CME Group in Q1 2018 and held it in 3 quarters.
  • Scholtz & Company's CME Group position peaked at $2.33M in Q2 2018.
  • 1,014 funds tracked by Wall St. Rank held CME Group as of Q4 2018.

Based on Scholtz & Company's 13F filing for Q4 2018, filed 29 Jan 2019.